ClinicalTrials.govpublic full text
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
metastatic hepatocellular carcinoma, solid tumors, solid tumor, adult, fgfr gene amplification, fgfr gene alterations, fgfr3 gene alteration, fgfr3 gene mutation, advanced solid tumors, fgfr4 gene mutation, fgfr4 gene fusions, fgf19 gene amplification, fgf19 gene overexpression
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 905128
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.